We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...

The facility, backed by UVA, CvilleBioHub and a $4.3 million GO Virginia award, will bring lab breakthroughs to health care.

AI optimizes existing knowledge but doesn't expedite drug approval or reduce costs compared to traditional methods. Explore ...

The industry continues to face financial and regulatory headwinds, including high interest rates and uncertainty about ...